Efficacy of leucocyte in platelet-rich plasma in lateral epicondylitis

Comparison efficacy of autologous leukocyte rich Platelet-rich plasma and leukocyte poor Platelet-rich plasma for the treatment of lateral epicondylitis: A randomized controlled study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005629

Enrollment

Registered

2020-11-24

Start date

2020-11-30

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Biological/Vaccine, Non-Stem Cell, Procedure/Surgery : Leukocyte rich platelet rich plasma Fill 6ml of ACD-A (citrate anticoagulant) in one 60ml syringe, and use a 18-gauge needle to draw 54ml of ve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Criteria for participation included lateral epicondylitis for longer than 6 months and pain of at least 50 on a visual analog score (VAS) for pain (0, no pain; 100 maximum pain possible).

Exclusion criteria

Exclusion criteria: age less than 18 years, pregnancy, history of carpal tunnel syndrome or cervical radiculopathy, and systemic disorders such as rheumatoid arthritis. Also, patients were excluded if they had been treated for lateral epicondylitis with surgical intervention or with a corticosteroid injection in the past 3 months.

Design outcomes

Primary

Measure	Time frame
Visual analogue scale, Disabilities of the Arm, Shoulder, and Hand score	—

Secondary

Measure	Time frame
Ultrasonography evaluation;Early complication related to injection of platelet-rich plasma	—

Countries

Korea, Republic of

Contacts

Public ContactHyoung-Seok Jung

Chung-Ang Univerisity Hospital

ksjhs5739@naver.com+82-2-6299-3109

Outcome results